Mitchell Smith - Dissemin

Papers authored by Mitchell Smith

This paper is available in a repository.

2014 Mitchell R. Smith

, Fang Jin, Indira Joshi

Milatuzumab and veltuzumab induce apoptosis through JNK signalling in an NF‐κB dependent human transformed follicular lymphoma cell line

Download from www.researchgate.net

This paper was not found in any repository, but could be made available legally by the author.

2013 Mitchell R. Smith

Is Early Hematopoietic Stem-Cell Transplantation Necessary in Mantle-Cell Lymphoma?

Upload

Fernando Arias-Mendoza, Geoffrey S. Payne, Kristen Zakian, Marion Stubbs, Owen A. O'Connor, Hamed Mojahed, Mitchell R. Smith

, Adam J. Schwarz, Amita Shukla-Dave, Franklyn Howe, Harish Poptani, Seung-Cheol Lee, Ruth Pettengel, Steven J. Schuster, David Cunningham

and 6 other authors

Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma

Download from www.ncbi.nlm.nih.gov

Danielle Shafer, Mitchell R. Smith

, Hossein Borghaei, Michael M. Millenson, Tianyu Li, Samuel Litwin, Rachna Anad, Tahseen Al-Saleem

Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma

Download from www.ncbi.nlm.nih.gov

T. H. Han, R. Chen, R. Advani, R. B. Berryman, S. E. Smith, A. Forero-Torres, J. D. Rosenblatt, M. R. Smith

, J. Zain, N. N. Hunder, A. Engert

Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignancies

Download from www.ncbi.nlm.nih.gov

Distributing this paper is prohibited by the publisher

Francine M. Foss, Nelida Sjak-Shie, Andre Goy, Eric Jacobsen, Ranjana Advani, Mitchell R. Smith

, Rami Komrokji, Kelly Pendergrass, Vanessa Bolejack

A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

A. P. Skarbnik, M. R. Smith

Therapies for mantle cell lymphoma: Current challenges and a brighter future

Upload

D. Jagadeesh, M. R. Smith

Novel targeted therapies in peripheral T cell lymphoma

Upload

This paper is made freely available by the publisher.

Luis Fayad, Fritz Offner, Mitchell R. Smith

, Gregor Verhoef, Peter Johnson, Jonathan L. Kaufman, Ama Rohatiner, Anjali Advani, James Foran, Georg Hess, Bertrand Coiffier, Myron Czuczman, Eva Gine, Simon Durrant, Michelle Kneissl and 5 other authors

Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab

Download from doi.org

2012 M. R. Smith

, I. Joshi, J. Pei, M. Slifker, F. Jin, J. R. Testa, T. Al-Saleem

Murine mantle cell lymphoma model cell line

Upload

Robert F. Weiss, Merlin G. Miller, John F. Cronin, Harvey H. Hensley, Indira D. Joshi, Mitchell R. Smith

Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma

Download from doi.org

Mitchell R. Smith

, Hailun Li, Leo Gordon, Randy D. Gascoyne, Elisabeth Paietta, Andres Forero-Torres, Brad S. Kahl, Ranjana Advani, Fangxin Hong, Sandra J. Horning

Phase II Study of Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Immunochemotherapy Followed by Yttrium-90–Ibritumomab Tiuxetan in Untreated Mantle-Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499

Download from www.ncbi.nlm.nih.gov

Neil Beeharry, Jerome B. Rattner, Alfonso Bellacosa, Mitchell R. Smith

, Timothy J. Yen

Dose Dependent Effects on Cell Cycle Checkpoints and DNA Repair by Bendamustine

Download from doi.org

Fengdong Cheng, Hongwei Wang, Pedro Horna, Zi Wang, Bijal Shah, Eva Sahakian, Karrune V. Woan, Alejandro Villagra, Javier Pinilla-Ibarz, Said Sebti, Mitchell Smith

, Jianguo Tao, Eduardo M. Sotomayor

Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Download from cancerres.aacrjournals.org

Peter Martin, Mitchell Smith

, Brian Till

Management of mantle cell lymphoma in the elderly

Upload

Alan P. Skarbnik, Mitchell R. Smith

Radioimmunotherapy in Mantle Cell Lymphoma

Download from www.ncbi.nlm.nih.gov

Christine K. White, Tahseen Al-Saleem, Alan Pz Skarbnik, Mitchell R. Smith

Tetanus toxoid reactive lymphadenopathy masquerading as T-cell lymphoma

Upload

Alan P. Z. Skarbnik, Mitchell R. Smith

Brentuximab vedotin in anaplastic large cell lymphoma

Upload

John P. Leonard, Ann S. LaCasce, Mitchell R. Smith

, Ariela Noy, Lucian R. Chirieac, Scott J. Rodig, Jian Q. Yu, Shankar Vallabhajosula, Heiko Schoder, Patricia English, Donna S. Neuberg, Peter Martin, Michael M. Millenson, Scott A. Ely, Rachel Courtney and 7 other authors

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

Download from ashpublications.org

Andres Forero-Torres, Sven de Vos, Brad L. Pohlman, Maksim Pashkevich, Damien M. Cronier, Nam H. Dang, Susan P. Carpenter, Barrett W. Allan, James G. Nelson, Christopher A. Slapak, Mitchell R. Smith

, Brian K. Link

, James E. Wooldridge, Kristen N. Ganjoo

Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma

Download from aacrjournals.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Mitchell Smith